$1.68
-0.01-0.59%
마지막 업데이트: Oct 15, 7:22 PM
$1.64
-0.0478-2.83%
Benzinga
Benzinga
Benzinga
금요일, 10월 16
Benzinga
© 2026 Benzinga | All Rights Reserved
Lipocine (LPCN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.41 | $-0.49 | $-0.61 | $-0.55 |
| Actual | $-0.32 | $-0.54 | $-0.34 | $-0.59 |
| Surprise | +21.9% | -10.2% | +44.3% | -7.27% |
| Revenue | ||||
| Estimate | $190400 | $150000 | $109600 | $182800 |
| Actual | $190099 | $119397 | $1.1M | $114574 |
| Surprise | -0.16% | -20.4% | +944.7% | -37.3% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.36 | $-0.36 |
| Revenue | ||
| Consensus | $147600 | $150000 |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $-0.32 | $-0.41 | 21.9 % |
| Q1 | May 7, 2026 | $-0.54 | $-0.49 | -10.2 % |
| Q4 | Mar 10, 2026 | $-0.34 | $-0.61 | 44.3 % |
| Q3 | Nov 6, 2025 | $-0.59 | $-0.55 | -7.27 % |
| 회계 분기 | 보고된 날짜 | 실제 수익 | 예상 수익 | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $190.10K | $190.40K | -0.16 % |
| Q1 | May 7, 2026 | $119.40K | $150.00K | -20.4 % |
| Q4 | Mar 10, 2026 | $1.15M | $109.60K | 944.7 % |
| Q3 | Nov 6, 2025 | $114.57K | $182.80K | -37.3 % |